Stay updated on Quizartinib With Azacitidine in AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib With Azacitidine in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T19:29:30.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new study-record version was added, dated 2026-09-30, with changes to Study Status; the displayed last-update date is now 2026-10-23 instead of 2025-04-06.
    Difference
    0.6%
    Check dated 2026-10-24T22:15:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T22:05:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T22:05:08.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a new site revision tag, updating from v3.6.6 to v3.7.0. This indicates a version update rather than a change to the trial data or history.
    Difference
    0.1%
    Check dated 2026-09-19T22:02:56.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.6.6, replacing v3.6.5, indicating a new platform release. This update does not modify any study data or study-related content.
    Difference
    0.1%
    Check dated 2026-08-29T19:02:38.000Z thumbnail image

Stay in the know with updates to Quizartinib With Azacitidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.